51 related articles for article (PubMed ID: 25976888)
1. The impact of taxane-based preoperative chemotherapy in gastroesophageal signet ring cell adenocarcinomas.
Kim S; Fiteni F; Paget-Bailly S; Ghiringhelli F; Lakkis Z; Jary M; Fein F; Bonnetain F; Mariette C; Borg C
J Hematol Oncol; 2015 May; 8():52. PubMed ID: 25976888
[TBL] [Abstract][Full Text] [Related]
2. Systemic chemotherapy and surgical cytoreduction for poorly differentiated and signet ring cell adenocarcinomas of the appendix.
Lieu CH; Lambert LA; Wolff RA; Eng C; Zhang N; Wen S; Rafeeq S; Taggart M; Fournier K; Royal R; Mansfield P; Overman MJ
Ann Oncol; 2012 Mar; 23(3):652-658. PubMed ID: 21653683
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological factors affecting the effect of neoadjuvant chemotherapy in patients with gastric cancer.
Jiang L; Ma Z; Ye X; Kang W; Yu J
World J Surg Oncol; 2021 Feb; 19(1):44. PubMed ID: 33563277
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant Immunotherapy in Gastroesophageal Cancer: A Promising Early Signal?
Zhu M; Yoon HH
J Clin Oncol; 2024 Feb; 42(4):373-377. PubMed ID: 37963321
[No Abstract] [Full Text] [Related]
5. Neoadjuvant Therapy Improves Outcomes in Locally Advanced Signet-Ring-Cell Containing Esophagogastric Adenocarcinomas.
Heger U; Sisic L; Nienhüser H; Blank S; Hinz U; Haag GM; Ott K; Ulrich A; Büchler MW; Schmidt T
Ann Surg Oncol; 2018 Aug; 25(8):2418-2427. PubMed ID: 29855828
[TBL] [Abstract][Full Text] [Related]
6. Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challenge.
Pernot S; Voron T; Perkins G; Lagorce-Pages C; Berger A; Taieb J
World J Gastroenterol; 2015 Oct; 21(40):11428-38. PubMed ID: 26523107
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of frequent CLDN18-ARHGAP26/6 fusion in gastric signet-ring cell cancer.
Shu Y; Zhang W; Hou Q; Zhao L; Zhang S; Zhou J; Song X; Zhang Y; Jiang D; Chen X; Wang P; Xia X; Liao F; Yin D; Chen X; Zhou X; Zhang D; Yin S; Yang K; Liu J; Fu L; Zhang L; Wang Y; Zhang J; An Y; Cheng H; Zheng B; Sun H; Zhao Y; Wang Y; Xie D; Ouyang L; Wang P; Zhang W; Qiu M; Fu X; Dai L; He G; Yang H; Cheng W; Yang L; Liu B; Li W; Dong B; Zhou Z; Wei Y; Peng Y; Xu H; Hu J
Nat Commun; 2018 Jun; 9(1):2447. PubMed ID: 29961079
[TBL] [Abstract][Full Text] [Related]
8. Signet Ring Cells and Efficacy of First-line Chemotherapy in Advanced Gastric or Oesogastric Junction Adenocarcinoma.
Lemoine N; Adenis A; Bouche O; Duhamel A; Heurgue A; Leteurtre E; Amela E; Salleron J; Hebbar M
Anticancer Res; 2016 Oct; 36(10):5543-5549. PubMed ID: 27798928
[TBL] [Abstract][Full Text] [Related]
9. Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial.
Al-Batran SE; Hofheinz RD; Pauligk C; Kopp HG; Haag GM; Luley KB; Meiler J; Homann N; Lorenzen S; Schmalenberg H; Probst S; Koenigsmann M; Egger M; Prasnikar N; Caca K; Trojan J; Martens UM; Block A; Fischbach W; Mahlberg R; Clemens M; Illerhaus G; Zirlik K; Behringer DM; Schmiegel W; Pohl M; Heike M; Ronellenfitsch U; Schuler M; Bechstein WO; Königsrainer A; Gaiser T; Schirmacher P; Hozaeel W; Reichart A; Goetze TO; Sievert M; Jäger E; Mönig S; Tannapfel A
Lancet Oncol; 2016 Dec; 17(12):1697-1708. PubMed ID: 27776843
[TBL] [Abstract][Full Text] [Related]
10. A Rare Case of Primary Gastric Signet Ring Cell Carcinoma: a Review of Guidelines for the Management of Gastric Cancer.
Montecino RMB; Sukhorosl M; Francis MA; Kancherla N; Akuma O; Nwangene NL; Nandyal S; Raj R; Akuma CM; Zahdeh T; Kaushik S; Khan AM
Indian J Surg Oncol; 2024 Mar; 15(1):153-159. PubMed ID: 38511028
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemotherapy outcome with taxane-based versus non-taxane protocols in gastric cancer.
Kianersi S; Salari S; Rezvani H; Araskhan MA; Shirangi A; Fathi MR; Ghorbi MD
J Educ Health Promot; 2023; 12():205. PubMed ID: 37545995
[TBL] [Abstract][Full Text] [Related]
12. Current trends in perioperative treatment of resectable gastric cancer.
Yıldız İ; Özer L; Şenocak Taşçı E; Bayoglu İV; Aytac E
World J Gastrointest Surg; 2023 Mar; 15(3):323-337. PubMed ID: 37032791
[TBL] [Abstract][Full Text] [Related]
13. Survival analysis and individualized prediction of survival benefit for pancreatic signet ring cell carcinoma: a population study based on the SEER database.
Nie D; Yang J; Zheng H; Lai G; Wang F; Cao J; Gong C
BMC Gastroenterol; 2023 Mar; 23(1):62. PubMed ID: 36894876
[TBL] [Abstract][Full Text] [Related]
14. Molecular profiling of signet-ring-cell carcinoma (SRCC) from the stomach and colon reveals potential new therapeutic targets.
Puccini A; Poorman K; Catalano F; Seeber A; Goldberg RM; Salem ME; Shields AF; Berger MD; Battaglin F; Tokunaga R; Naseem M; Zhang W; Philip PA; Marshall JL; Korn WM; Lenz HJ
Oncogene; 2022 Jun; 41(26):3455-3460. PubMed ID: 35618879
[TBL] [Abstract][Full Text] [Related]
15. Signet-ring cell carcinoma of the duodenal bulb presenting with gastrointestinal hemorrhage: a case report and literature review.
Ye N; Bao X; Zhao X; Wang B
BMC Gastroenterol; 2022 May; 22(1):226. PubMed ID: 35534806
[TBL] [Abstract][Full Text] [Related]
16. Impact of neoadjuvant therapy followed by laparoscopic radical gastrectomy with D2 lymph node dissection in Western population: A multi-institutional propensity score-matched study.
Bracale U; Corcione F; Pignata G; Andreuccetti J; Dolce P; Boni L; Cassinotti E; Olmi S; Uccelli M; Gualtierotti M; Ferrari G; De Martini P; Bjelović M; Gunjić D; Cuccurullo D; Sciuto A; Pirozzi F; Peltrini R
J Surg Oncol; 2021 Dec; 124(8):1338-1346. PubMed ID: 34432291
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Nomograms for Nonelderly Adults with Gastric Signet Ring Cell Carcinoma.
Wang H; Peng Y; Huang Q; Wu J; Zhang M
Biomed Res Int; 2021; 2021():1274527. PubMed ID: 33834061
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of poorly cohesive gastric carcinoma in Tunisian patients.
Jouini R; Khanchel F; Sabbah M; Helal I; Gharsallah A; Ferchichi M; Hadded D; Zaafouri H; Ben Brahim E; Ben Maamer A; Debbiche AC
Heliyon; 2020 Mar; 6(3):e03460. PubMed ID: 32195384
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant chemotherapy
Li Y; Ma FH; Xue LY; Tian YT
World J Gastroenterol; 2020 Feb; 26(8):818-827. PubMed ID: 32148379
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
